Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 14;14(20):2279.
doi: 10.3390/diagnostics14202279.

Artificial Intelligence in Uropathology

Katia Ramos Moreira Leite  1 , Petronio Augusto de Souza Melo  1
Affiliations
Review

Artificial Intelligence in Uropathology

Katia Ramos Moreira Leite et al. Diagnostics (Basel). .

Abstract

The global population is currently at unprecedented levels, with an estimated 7.8 billion people inhabiting the planet. We are witnessing a rise in cancer cases, attributed to improved control of cardiovascular diseases and a growing elderly population. While this has resulted in an increased workload for pathologists, it also presents an opportunity for advancement. The accurate classification of tumors and identification of prognostic and predictive factors demand specialized expertise and attention. Fortunately, the rapid progression of artificial intelligence (AI) offers new prospects in medicine, particularly in diagnostics such as image and surgical pathology. This article explores the transformative impact of AI in the field of uropathology, with a particular focus on its application in diagnosing, grading, and prognosticating various urological cancers. AI, especially deep learning algorithms, has shown significant potential in improving the accuracy and efficiency of pathology workflows. This comprehensive review is dedicated to providing an insightful overview of the primary data concerning the utilization of AI in diagnosing, predicting prognosis, and determining drug responses for tumors of the urinary tract. By embracing these advancements, we can look forward to improved outcomes and better patient care.

Keywords: artificial intelligence; bladder cancer; diagnosis; prognosis; prostate cancer; renal cell cancer; uropathology.

PubMed Disclaimer

Conflict of interest statement

We declare that we do not have any conflicts of interest regarding this article.

References

    1. Kim I., Kang K., Song Y., Kim T.J. Application of Artificial Intelligence in Pathology: Trends and Challenges. Diagnostics. 2022;12:2794. doi: 10.3390/diagnostics12112794. - DOI - PMC - PubMed
    1. Jiang Y., Yang M., Wang S., Li X., Sun Y. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun. 2020;40:154–166. doi: 10.1002/cac2.12012. - DOI - PMC - PubMed
    1. Pantanowitz L., Quiroga-Garza G.M., Bien L., Heled R., Laifenfeld D., Linhart C., Sandbank J., Albrecht Shach A., Shalev V., Vecsler M., et al. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: A blinded clinical validation and deployment study. Lancet Digit. Health. 2020;2:e407–e416. doi: 10.1016/S2589-7500(20)30159-X. - DOI - PubMed
    1. Bulten W., Pinckaers H., van Boven H., Vink R., de Bel T., van Ginneken B., van der Laak J., Hulsbergen-van de Kaa C., Litjens G. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: A diagnostic study. Lancet Oncol. 2020;21:233–241. doi: 10.1016/S1470-2045(19)30739-9. - DOI - PubMed
    1. Tsuneki M., Abe M., Kanavati F. Deep Learning-Based Screening of Urothelial Carcinoma in Whole Slide Images of Liquid-Based Cytology Urine Specimens. Cancers. 2022;15:226. doi: 10.3390/cancers15010226. - DOI - PMC - PubMed

LinkOut - more resources